These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6478051

  • 1. Cardiac and antiarrhythmic effects of imipramine in patients with ventricular arrhythmias.
    Giardina EG.
    Biomed Pharmacother; 1984; 38(3):128-30. PubMed ID: 6478051
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic plasma-concentration range of imipramine against ventricular premature depolarizations.
    Giardina EG, Louie M, Bigger JT, Brem R, Alchevsky D.
    Clin Pharmacol Ther; 1983 Sep; 34(3):284-9. PubMed ID: 6883904
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T, Kasper W, Kersting F, Bechtold H, Just H, Jähnchen E.
    Arzneimittelforschung; 1980 Sep; 30(9):1593-5. PubMed ID: 7193031
    [Abstract] [Full Text] [Related]

  • 4. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ, Blatt CM.
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [Abstract] [Full Text] [Related]

  • 5. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G, Capucci A, Strocchi E, Calliva R, Santarelli A, Biffi M, Magnani B.
    Int J Clin Pharmacol Res; 1993 Apr; 13(4):211-9. PubMed ID: 8150547
    [Abstract] [Full Text] [Related]

  • 6. [Assessment of ventricular arrhythmias].
    Osswald S, Rickenbacher P, Buser PT, Pfisterer M.
    Praxis (Bern 1994); 1996 Feb 13; 85(7):179-87. PubMed ID: 8701182
    [Abstract] [Full Text] [Related]

  • 7. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 13; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 8. [Ventricular arrhythmias: diagnosis and drug therapy].
    Schüpfer C, Gertsch M.
    Praxis (Bern 1994); 1996 May 14; 85(20):647-54. PubMed ID: 8685556
    [Abstract] [Full Text] [Related]

  • 9. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE, Kaplan HR.
    J Pharmacol Exp Ther; 1982 Nov 14; 223(2):580-6. PubMed ID: 7131307
    [Abstract] [Full Text] [Related]

  • 10. The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations.
    Giardina EG, Bigger JT, Glassman AH, Perel JM, Kantor SJ.
    Circulation; 1979 Nov 14; 60(5):1045-52. PubMed ID: 487538
    [Abstract] [Full Text] [Related]

  • 11. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 14; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between late ventricular potentials and ventricular arrhythmias in patients in chronic dialysis treatment].
    Pomini G, Salvo P, Torchiarella C, Lucangeli A, Ruffatti A, Naso A, Gribaldo R.
    Minerva Cardioangiol; 1997 Apr 14; 45(4):155-65. PubMed ID: 9213830
    [Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic effect of imipramine hydrochloride in patients with ventricular premature complexes without psychological depression.
    Giardina EG, Bigger JT.
    Am J Cardiol; 1982 Jul 14; 50(1):172-9. PubMed ID: 6178282
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research].
    Beck OA, Spielmann H, Witt E, Oeff M, Liddard C, Hochrein H.
    Arzneimittelforschung; 1980 Jul 14; 30(12):2172-81. PubMed ID: 7194081
    [Abstract] [Full Text] [Related]

  • 16. Oral amiodarone in high-risk ventricular arrhythmias.
    Toruncha A, García-Barreto D, González-Gómez A, Llerena L, Sellén J, Ramos-Emperador C, Cabrera-Alonso C, Hernández-Cañero A.
    Cor Vasa; 1982 Jul 14; 24(5):354-64. PubMed ID: 7172689
    [Abstract] [Full Text] [Related]

  • 17. Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias.
    Giardina EG, Johnson LL, Vita J, Bigger JT, Brem RF.
    Am Heart J; 1985 May 14; 109(5 Pt 1):992-8. PubMed ID: 3993532
    [Abstract] [Full Text] [Related]

  • 18. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias.
    Somberg JC, Cao W, Cvetanovic I, Ranade VV, Molnar J.
    Am J Ther; 2005 May 14; 12(3):218-22. PubMed ID: 15891264
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T, Kasper W, Stengel E, Waldecker B, Löllgen H, Jähnchen E, Bechtold H, Just J.
    Z Kardiol; 1982 Jan 14; 71(1):35-8. PubMed ID: 7039160
    [Abstract] [Full Text] [Related]

  • 20. [Type and frequency of cardiac arrhythmias dependent on age, therapeutic aspects (author's transl)].
    Wiese KH, Walter J, Schramm A, Gärtner FR, Bracharz M.
    Z Kardiol; 1981 Jul 14; 70(7):516-23. PubMed ID: 6168125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.